Entrectinib Effective across NTRK Fusion-Positive Cancers

    Cancer Discovery
    |November 29, 2018
    PubMed

    Insights

    Entrectinib shows promise for solid tumors with NTRK gene fusions. Over half of patients responded, including those with brain metastases, indicating broad efficacy.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare but actionable drivers in various solid tumors.
    • Targeted therapies offer new treatment avenues for patients with specific genetic alterations.

    Discussion:

    • Entrectinib demonstrated significant clinical activity in a combined analysis of Phase I and II trials.
    • The drug's efficacy was observed across diverse tumor types harboring NTRK fusions.
    • Central nervous system (CNS) activity was notable, with a comparable response rate in patients with brain metastases.

    Key Insights:

    • Entrectinib is a potential therapeutic option for NTRK fusion-positive solid tumors.
    • Tumor-agnostic efficacy supports its use irrespective of primary tumor site.
    • Brain penetration and activity are crucial for patients with metastatic disease.

    Outlook:

    • Further investigation into long-term outcomes and resistance mechanisms is warranted.
    • Entrectinib may become a standard of care for NTRK fusion-positive cancers.
    • Exploration in combination therapies could enhance patient response and survival.

    Related Concept Videos

    Nuclear Fusion02:45

    Nuclear Fusion

    The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
    A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
    33.9K
    Position-effect Variegation02:32

    Position-effect Variegation

    In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
    7.1K
    Chromatin Position Affects Gene Expression02:35

    Chromatin Position Affects Gene Expression

    Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
    Topologically Associated Domains (TADs)
    The 3-dimensional positioning of chromatin in the nucleus influences the...
    24.8K
    Serial Position Effect01:03

    Serial Position Effect

    The serial position effect is a cognitive phenomenon where individuals are more likely to recall the first and last items in a list compared to those in the middle. This effect is divided into the primacy effect and the recency effect. The primacy effect is observed when the initial items in a list are remembered better. This occurs because these items are rehearsed more frequently or receive more elaborative processing, allowing them to be encoded into long-term memory more effectively. For...
    543
    Tagging and Fusion Proteins01:24

    Tagging and Fusion Proteins

    Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
    8.5K
    SNAREs and Membrane Fusion01:43

    SNAREs and Membrane Fusion

    Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
    SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
    12.8K